Abstract:Background: Stroke severity is worsened by recruitment of inflammatory immune cells into the brain. This process depends in part on T cell activation, in which the B7 family of co-stimulatory molecules plays a pivotal role. Previous studies demonstrated more severe infarcts in mice lacking programmed death-1 (PD-1), a member of the B7 family, thus implicating PD-1 as a key factor in limiting stroke severity. The purpose of this study was to determine if this protective effect of PD-1 involves either of its ligands, PD-L1 or PD-L2. Methods: Central nervous system (CNS) inflammation and infarct volume were evaluated in male PD-L1 and PD-L2 knockout (-/-) mice undergoing 60 minutes of middle cerebral artery occlusion (MCAO) followed by 96 hours of reperfusion and compared to wild-type (WT) C57BL/6J mice. Results: PD-L1-/- and PD-L2-/- mice had smaller total infarct volumes compared to WT mice. The PD-L1-/- and to a lesser extent PD-L2-/- mice had reduced levels of proinflammatory activated microglia and/or infiltrating monocytes and CD4+ T cells in the ischemic hemispheres. There was a reduction in ischemia-related splenic atrophy accompanied by lower activation status of splenic T cells and monocytes in the absence of PD-L1, suggesting a pathogenic rather than a regulatory role for both PD-1 ligands (PD-Ls). Suppressor T cells (IL-10-producing CD8+CD122+ T cells) trafficked to the brain in PD-L1-/- mice and there was decreased expression of CD80 on splenic antigen-presenting cells (APCs) as compared to the WT and PD-L2-/- mice. Conclusions: Our novel observations are the first to implicate PD-L1 involvement in worsening outcome of experimental stroke. The presence of suppressor T cells in the right MCAO-inflicted hemisphere in mice lacking PD-L1 implicates these cells as possible key contributors for controlling adverse effects of ischemia. Increased expression of CD80 on APCs in WT and PD-L2-/- mice suggests an overriding interaction leading to T cell activation. Conversely, low CD80 expression by APCs, along with increased PD-1 and PD-L2 expression in PD-L1-/- mice suggests alternative T cell signaling pathways, leading to a suppressor phenotype. These results suggest that agents (for example antibodies) that can target and neutralize PD-L1/2 may have therapeutic potential for treatment of human stroke.

Abstract TP253: Double Negative T Cells with FasL Mutation Promote M2-Microglial Polarization by Inhibiting PTPN2/TNF-α Pathway in Experimental Stroke

Abstract T P222: Fasl Mutation Facilitates Double Negative T Cell Accumulation and Modulates Microglia Activation in Ischemic Stroke

Double-negative T cells remarkably promote neuroinflammation after ischemic stroke

Polarization of Microglia to the M2 Phenotype in A Peroxisome Proliferator-Activated Receptor Gamma-Dependent Manner Attenuates Axonal Injury Induced by Traumatic Brain Injury in Mice

Abstract TP257: Fasl Enhances Cytotoxicity of CD8 + T Cells after Ischemic Stroke

Abstract WP104: Neuron- Microglia Crosstalk Mediated by Soluble Fas Ligand after Ischemic Stroke

Abstract T P202: Crosstalk Between Microglia and T Cells Mediated by FasL after Cerebral Ischemia

FasL Incapacitation Alleviates CD4+ T Cells-Induced Brain Injury Through Remodeling of Microglia Polarization in Mouse Ischemic Stroke.

T Cells Modulate the Microglial Response to Brain Ischemia

Abstract WMP73: Peripheral T Cells From MCAO Mice Contribute to Microglial Polarization

Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke

Improving stroke prognosis by TLR4 KO to enhance N2 neutrophil infiltration and reduce M1 macrophage polarization

Double‐negative T cells mediate M1 polarization of microglial cells via TNF‐α‐NLRP3 to aggravate neuroinflammation and cognitive impairment in Alzheimer's disease mice

Mild Focal Hypothermia Regulates the Dynamic Polarization of Microglia after Ischemic Stroke in Mice

Neuronal Soluble Fas Ligand Drives M1‐Microglia Polarization after Cerebral Ischemia

TCRαβ + NK1.1 - CD4 - CD8 - double-negative T cells inhibit central and peripheral inflammation and ameliorate ischemic stroke in mice

Abstract 16: Inhibiting Ezh2 Is Neuroprotective After Stroke In Aged Mice

FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic Stroke.

Blocking PSD-93-CX3CL1 Interaction Promotes Phenotypic Polarization Transformation of Microglia During Acute Ischemic Stroke Injury

mtDNA-STING Axis Mediates Microglial Polarization via IRF3/NF-κB Signaling After Ischemic Stroke

PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1